Skip to main content
Journal cover image

Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance.

Publication ,  Journal Article
van Duin, D; Cober, ED; Richter, SS; Perez, F; Cline, M; Kaye, KS; Kalayjian, RC; Salata, RA; Evans, SR; Fowler, VG; Bonomo, RA
Published in: Clin Microbiol Infect
December 2014

Carbapenem-resistant Klebsiella pneumoniae (CRKP) is an increasing global threat. Here, we describe the prevalence and impact of tigecycline use in a cohort of patients with CRKP bacteriuria nested within a multicentre, prospective study. In the 21-month study period, 260 unique patients were included. Tigecycline was given to 80 (31%) patients. The use of tigecycline during the index hospitalization was significantly associated with the subsequent development of tigecycline resistance in the same patient (OR, 6.13; 95% CI, 1.15-48.65; p 0.03). In conclusion, the use of tigecycline with CRKP bacteriuria is common, and is associated with the subsequent development of tigecycline resistance.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Clin Microbiol Infect

DOI

EISSN

1469-0691

Publication Date

December 2014

Volume

20

Issue

12

Start / End Page

O1117 / O1120

Location

England

Related Subject Headings

  • Tigecycline
  • Sequence Analysis, DNA
  • Molecular Sequence Data
  • Minocycline
  • Middle Aged
  • Microbiology
  • Male
  • Klebsiella pneumoniae
  • Klebsiella Infections
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
van Duin, D., Cober, E. D., Richter, S. S., Perez, F., Cline, M., Kaye, K. S., … Bonomo, R. A. (2014). Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance. Clin Microbiol Infect, 20(12), O1117–O1120. https://doi.org/10.1111/1469-0691.12714
Duin, D. van, E. D. Cober, S. S. Richter, F. Perez, M. Cline, K. S. Kaye, R. C. Kalayjian, et al. “Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance.Clin Microbiol Infect 20, no. 12 (December 2014): O1117–20. https://doi.org/10.1111/1469-0691.12714.
van Duin D, Cober ED, Richter SS, Perez F, Cline M, Kaye KS, et al. Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance. Clin Microbiol Infect. 2014 Dec;20(12):O1117–20.
van Duin, D., et al. “Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance.Clin Microbiol Infect, vol. 20, no. 12, Dec. 2014, pp. O1117–20. Pubmed, doi:10.1111/1469-0691.12714.
van Duin D, Cober ED, Richter SS, Perez F, Cline M, Kaye KS, Kalayjian RC, Salata RA, Evans SR, Fowler VG, Bonomo RA. Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance. Clin Microbiol Infect. 2014 Dec;20(12):O1117–O1120.
Journal cover image

Published In

Clin Microbiol Infect

DOI

EISSN

1469-0691

Publication Date

December 2014

Volume

20

Issue

12

Start / End Page

O1117 / O1120

Location

England

Related Subject Headings

  • Tigecycline
  • Sequence Analysis, DNA
  • Molecular Sequence Data
  • Minocycline
  • Middle Aged
  • Microbiology
  • Male
  • Klebsiella pneumoniae
  • Klebsiella Infections
  • Humans